Corticotropin-Releasing Factor Receptor-1 Neurons in the Lateral Amygdala Display Selective Sensitivity to Acute and Chronic Ethanol Exposure.

Alcoholism Amygdala / metabolism Animals Corticotropin-Releasing Hormone / metabolism Ethanol / pharmacology Male Mice Neurons / metabolism Receptors, Corticotropin-Releasing Hormone / metabolism gamma-Aminobutyric Acid
CRF CRF1 receptor GABA alcohol basolateral amygdala lateral amygdala

Journal

eNeuro
ISSN: 2373-2822
Titre abrégé: eNeuro
Pays: United States
ID NLM: 101647362

Informations de publication

Date de publication:
Historique:
received: 10 10 2019
revised: 15 01 2020
accepted: 28 01 2020
pubmed: 12 2 2020
medline: 22 6 2021
entrez: 12 2 2020
Statut: epublish

Résumé

The lateral amygdala (LA) serves as the point of entry for sensory information within the amygdala complex, a structure that plays a critical role in emotional processes and has been implicated in alcohol use disorders. Within the amygdala, the corticotropin-releasing factor (CRF) system has been shown to mediate some of the effects of both stress and ethanol, but the effects of ethanol on specific CRF1 receptor circuits in the amygdala have not been fully established. We used male CRF1:GFP reporter mice to characterize CRF1-expressing (CRF1

Identifiants

DOI: 10.1523/ENEURO.0420-19.2020 PMID: 32041742 PMC: PMC7059189
pubmed: 32041742
pii: ENEURO.0420-19.2020
doi: 10.1523/ENEURO.0420-19.2020
pmc: PMC7059189
pii:
doi:

Substances chimiques

Receptors, Corticotropin-Releasing Hormone 0
Ethanol 3K9958V90M
gamma-Aminobutyric Acid 56-12-2
CRF receptor type 1 5CLY6W2H1M
Corticotropin-Releasing Hormone 9015-71-8

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAAA NIH HHS
ID : R00 AA025393
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA013498
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA016985
Pays : United States
Organisme : NINDS NIH HHS
ID : T32 NS007431
Pays : United States
Organisme : NIAAA NIH HHS
ID : T32 AA007573
Pays : United States
Organisme : NIAAA NIH HHS
ID : T32 AA007456
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA017447
Pays : United States
Organisme : NIAAA NIH HHS
ID : K99 AA023002
Pays : United States
Organisme : NIAAA NIH HHS
ID : P60 AA006420
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA015566
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA021491
Pays : United States
Organisme : NIAAA NIH HHS
ID : K99 AA025393
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA027700
Pays : United States
Organisme : NIAAA NIH HHS
ID : R00 AA023002
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA026685
Pays : United States
Organisme : NIAAA NIH HHS
ID : P60 AA011605
Pays : United States

Informations de copyright

Copyright © 2020 Agoglia et al.

Références

Pharmacol Biochem Behav. 2017 Dec;163:20-29
pubmed: 29100991
Proc Natl Acad Sci U S A. 2016 Jan 26;113(4):1086-91
pubmed: 26755579
Addict Biol. 2019 Nov;24(6):1204-1215
pubmed: 30421483
J Neurosci. 2004 Sep 22;24(38):8379-82
pubmed: 15385620
J Comp Neurol. 2000 Dec 11;428(2):191-212
pubmed: 11064361
J Neurosci. 2016 Oct 19;36(42):10729-10741
pubmed: 27798128
Neuron. 2007 Dec 6;56(5):763-70
pubmed: 18054854
Neuron. 2004 Sep 30;44(1):75-91
pubmed: 15450161
Psychopharmacology (Berl). 1998 Sep;139(1-2):2-19
pubmed: 9768538
Alcohol Clin Exp Res. 1998 Aug;22(5):998-1040
pubmed: 9726269
Alcohol. 2018 Nov;72:61-73
pubmed: 30220589
Int Rev Neurobiol. 2010;91:205-33
pubmed: 20813244
Trends Neurosci. 2004 May;27(5):262-9
pubmed: 15111008
Pharmacol Biochem Behav. 2004 Feb;77(2):405-13
pubmed: 14751471
J Neurosci. 2004 Apr 7;24(14):3471-9
pubmed: 15071094
J Neurophysiol. 2007 Dec;98(6):3185-96
pubmed: 17898152
J Neurosci. 2013 Feb 20;33(8):3284-98
pubmed: 23426657
J Neurosci. 2004 Nov 10;24(45):10159-66
pubmed: 15537886
J Comp Neurol. 2008 Dec 1;511(4):479-96
pubmed: 18853426
J Neurochem. 2009 Dec;111(5):1172-81
pubmed: 19765192
Pharmacol Ther. 2006 Sep;111(3):533-54
pubmed: 16427127
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15218-23
pubmed: 14625373
Nature. 2011 Mar 17;471(7338):358-62
pubmed: 21389985
Curr Top Behav Neurosci. 2013;13:31-86
pubmed: 21786203
Thalamus Relat Syst. 2005 Jun;3(2):115-120
pubmed: 19112524
Trends Neurosci. 1997 Nov;20(11):517-23
pubmed: 9364666
Alcohol Clin Exp Res. 1998 Feb;22(1):3-9
pubmed: 9514280
J Neurosci. 2009 Oct 14;29(41):12757-63
pubmed: 19828786
Alcohol. 2007 May;41(3):155-62
pubmed: 17521845
Physiol Rev. 2003 Jul;83(3):803-34
pubmed: 12843409
J Neurosci. 2012 Jun 20;32(25):8611-9
pubmed: 22723702
J Neurosci. 2002 May 15;22(10):RC223
pubmed: 12006605
Synapse. 2017 Apr;71(4):
pubmed: 27997737
Front Behav Neurosci. 2009 Oct 20;3:37
pubmed: 19876409
Addict Biol. 2018 Mar;23(2):723-734
pubmed: 28660730
Mol Pharmacol. 1996 Mar;49(3):567-79
pubmed: 8643098
Front Behav Neurosci. 2008 Jul 16;2:2
pubmed: 18958192
Alcohol. 2007 May;41(3):145-53
pubmed: 17521846
Anal Chem. 2012 Jan 3;84(1):412-9
pubmed: 22118158
Neuropeptides. 2013 Aug;47(4):273-80
pubmed: 23688647
Biol Psychiatry. 2010 May 1;67(9):831-9
pubmed: 20060104
Neuroscience. 2007 Dec 19;150(4):818-28
pubmed: 17988803
Alcohol Clin Exp Res. 2018 Sep;42(9):1661-1673
pubmed: 29944190
J Pharmacol Exp Ther. 2011 Apr;337(1):162-70
pubmed: 21209156
Science. 2004 Mar 5;303(5663):1512-4
pubmed: 15001778
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14439-44
pubmed: 14623958
Mol Cell Neurosci. 2006 Sep;33(1):57-67
pubmed: 16861000
Neuroscience. 2000;101(4):815-50
pubmed: 11113332
J Neurosci. 2004 Feb 18;24(7):1594-603
pubmed: 14973247
Prog Mol Biol Transl Sci. 2014;122:263-304
pubmed: 24484705

Auteurs

Abigail E Agoglia (AE)

Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599.
Bowles Center for Alcohol Studies, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599.

ManHua Zhu (M)

Neuroscience Curriculum, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599.

Rose Ying (R)

Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599.
Bowles Center for Alcohol Studies, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599.

Harpreet Sidhu (H)

Department of Neuroscience, The Scripps Research Institute, La Jolla, California 92037.

Luis A Natividad (LA)

University of Texas at Austin, College of Pharmacy - Division of Pharmacology and Toxicology, Austin, TX 78712.

Sarah A Wolfe (SA)

Department of Neuroscience, The Scripps Research Institute, La Jolla, California 92037.

Matthew W Buczynski (MW)

School of Neuroscience, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061.

Candice Contet (C)

Department of Neuroscience, The Scripps Research Institute, La Jolla, California 92037.
ORCID: 0000-0002-4459-9540

Loren H Parsons (LH)

Department of Neuroscience, The Scripps Research Institute, La Jolla, California 92037.

Marisa Roberto (M)

Department of Neuroscience, The Scripps Research Institute, La Jolla, California 92037.

Melissa A Herman (MA)

Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 melissa_herman@unc.edu.
Bowles Center for Alcohol Studies, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Meal Timing and Anthropometric and Metabolic Outcomes: A Systematic Review and Meta-Analysis.

Hiu Yee Liu, Ashley A Eso, Nathan Cook et al.
1.00
Humans Meals Time Factors Female Adult

Classifications MeSH

questionsmedicales.fr › Troubles mentaux › Troubles liés à une substance › Troubles liés à l'alcool › Alcoolisme › Corticotropin-Releasing Factor Receptor-1...
questionsmedicales.fr › Système nerveux › Système nerveux central › Encéphale › Prosencéphale › Télencéphale › Cerveau › Noyaux gris centraux › Amygdale (système limbique) › Corticotropin-Releasing Factor Receptor-1...
questionsmedicales.fr › Eucaryotes › Animaux › Corticotropin-Releasing Factor Receptor-1...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines de tissu nerveux › Neuropeptides › Hormones hypothalamiques › Hormones hypophysiotropes libératrices › Corticolibérine › Corticotropin-Releasing Factor Receptor-1...
questionsmedicales.fr › Composés chimiques organiques › Alcools › Éthanol › Corticotropin-Releasing Factor Receptor-1...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Corticotropin-Releasing Factor Receptor-1...
questionsmedicales.fr › Cellules › Neurones › Corticotropin-Releasing Factor Receptor-1...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs peptidiques › Récepteur hormones hypothalamiques hypophysotropes régulatrices › Récepteur CRH › Corticotropin-Releasing Factor Receptor-1...
questionsmedicales.fr › Acides aminés, peptides et protéines › Acides aminés › Amino-butyrates › Acide gamma-amino-butyrique › Corticotropin-Releasing Factor Receptor-1...